Owner VAXIION Therapeutics, Inc.

Inventors Sabbadini, Roger A; Surber, Mark; Giacalone, Matthew; Berkley, Neil

Agent Fisher Adams Kelly

Pub. Number AU-B-2002318168

PCT Number PCT/US02/16877

PCT Pub. Number WO2003/072014

Priority 10/154,951 24.05.02 US; 60/359,843 25.02.02 US

Filing date 28 May 2002

Wipo publication date 9 September 2003

Acceptance publication date 13 December 2007

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/543 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with an insoluble carrier for immobilising immunochemicals

G01N 33/60 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving radioactive labelled substances